In the total cohort, approximately 15% of all patients had positive membranous tumour PD-L1 staining of ≥50%, and 71.2% of all patients had less than 1% membranous tumour PD-L1 staining (Supplementary Table 5; Fig. 2h). The gene discussed is CD274; the disease is neoplasm.